SCHEMBL4772963

SCHEMBL4772963

Cc1nccn1Cn1ccnc1C

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.59
ALDH1A1 P00352 2/20 0.59
POLB P06746 1/20 0.59
TSHR P16473 1/20 0.48
FDPS P14324 1/20 0.48
LMNA P02545 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
CA12 O43570 1/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
CA9 Q16790 1/20 0.44
ALPL P05186 2/20 0.42
ALPG P10696 2/20 0.42
ALPI P09923 1/20 0.42
PLAA Q9Y263 1/20 0.42
GFER P55789 1/20 0.41
MEN1 O00255 1/20 0.41
HPGD P15428 1/20 0.41
MAPT P10636 1/20 0.41
AGER Q15109 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4779659 0.84 ALDH1A1 (0.72) KMT2AALDH1A1POLBTSHRFDPS
SCHEMBL486434 0.82
SCHEMBL24540417 0.81
SCHEMBL1146945 0.80
Iodide SCHEMBL4268734 0.80
SCHEMBL25009512 0.80 ALDH1A1 (0.80) KMT2AALDH1A1POLBTSHRFDPS
SCHEMBL17012174 0.80
SCHEMBL11159270 0.80
SCHEMBL6647390 0.80
Bromide SCHEMBL1237833 0.80

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023191185-A1 SEPARATOR FOR RECHARGEABLE LITHIUM BATTERY AND RECHARGEABLE LITHIUM BATTERY INCLUDING SAME 삼성에스디아이 주식회사 2023-10-05 WO disclosed
EP-3708540-B1 A PREPARATION METHOD FOR ZEOLITIC IMIDAZOLATE FRAMEWORKS UNIV CHINA PETROLEUM BEIJING (CN) 2022-03-02 EP disclosed
US-10815253-B2 Preparation method for zeolitic imidazolate frameworks CHINA UNIVERSITY OF PETROLEUM-BEIJING (CN) 2020-10-27 US disclosed
US-20200291046-A1 PREPARATION METHOD FOR ZEOLITIC IMIDAZOLATE FRAMEWORKS CHINA UNIVERSITY OF PETROLEUM-BEIJING (CN) 2020-09-17 US disclosed
EP-1383497-B1 CARBONIC ANHYDRASE ACTIVATORS FOR ENHANCING LEARNING AND MEMORY BRNI NEUROSCIENCES INST (US) 2008-10-15 EP disclosed
EP-1935414-A2 Carbonic anhydrase activators for enhancig learning and memory Blanchette Rockefeller Neurosciences Institute (US) 2008-06-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200291046-A1 PREPARATION METHOD FOR ZEOLITIC IMIDAZOLATE FRAMEWORKS CA2, CA4, ILF2 KMT2A 1623/4885ALDH1A1 4822/4885POLB 4009/4885
US-10815253-B2 Preparation method for zeolitic imidazolate frameworks CA2, CA4, ILF2 KMT2A 1623/4885ALDH1A1 4822/4885POLB 4009/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.